Good earning, good outlook. This stock will go back to above $20.
Don't be tricked by the short sellers.
"Abiomed Announces Revenue of $37.4 Million, Up 27% and Worldwide Impella(R) Revenue Growth of 32%"
Sentiment: Strong Buy
Insurers may balk and subpoena- utilization will likely suffer. BUY CALLS LEAPS
Why the drop ???? I just don't get it